1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Breast Cancer in 1 studies
1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nieman, MT | 1 |
| Prudoff, RS | 1 |
| Johnson, KR | 1 |
| Wheelock, MJ | 1 |
1 other study available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Breast Cancer
| Article | Year |
|---|---|
N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression.
Topics: beta Catenin; Blotting, Western; Breast Neoplasms; Cadherins; Cell Movement; Cell Size; Coculture Te | 1999 |